Temasek Holdings reduced its stake in Sino Biopharmaceutical (01801.HK) by 3.0485 million shares at a price of approximately HK$51.98 per share.

According to the Wisdom Financial APP, the latest information from the Hong Kong Stock Exchange shows that on April 25th, Temasek Holdings Company reduced its holdings of Sino Biopharmaceutical (01801.HK) by 3.0485 million shares, with a price of HK$51.9847 per share, for a total amount of approximately HK$158 million. After the reduction, the latest number of shares held is approximately 115 million shares, with a new shareholding ratio of 6.96%.